Gregory Stock inspires and challenges audiences with a compelling vision of the far-reaching consequences of the biotech and Infotech revolutions. He provides clear perspective on the economic, political and social challenges that are emerging as big-data, digital-health, and other advanced technology comes of age, and shows how they will transform medicine, healthcare and our very selves. Stock makes the case for hope and possibility in this time of difficult, disruptive change.
- The Biotech Revolution: How it will Transform the Healthcare Sector
- From Darwin to Destiny: Glimpses of the Strange Future Ahead
- Big Data in Healthcare: Best Hope or Worst Fear?
- Courage to Question: Confronting Hard Choices in Business and Life
- The New Economics of Healthcare
- Prosthetics, Designer Babies, and Life Extension: What are the Limits?
- Where are the Wonder Drugs?
What he offers
How he presents
His presentations are provocative, engaging, accessible distillations of recent technological advances and how they will remake our lives and challenge our sense of what it is to be human. He provides a riveting, eye-opening glimpse of the sometimes dizzying future that is arriving far sooner than most people imagine. He is unforgettable.
Dr. Gregory Stock is a leading authority on the broad impacts of advanced technology in the life sciences. He is a professor at the Mt. Sinai School of Medicine in NY where he co-directs the Harris Center for Precision Wellness and is working on the foundations of nextgen wellness and healthcare. Previously, he founded and directed the Program on Medicine, Technology and Society at UCLA’s School of Medicine. He also co-founded and led two biotech companies: Signum Biosciences, a Princeton-based biopharmaceutical company developing therapeutics for Alzheimer’s, and Ecoeos, a personalized healthcare company that pioneered at-home genetic tests for vulnerability to toxicity from exposure to mercury.
Dr. Stock’s book, Redesigning Humans: Our Inevitable Genetic Future, won the Kistler Book Prize for Science books and was nominated for a Wired Rave Award. Among his other books are Engineering The Human Germline, Metaman, and The Book of Questions, which has sold 2 ½ million copies, been translated into 18 languages, and is approaching 100 printings. Sequels include The Kids’ Book of Questions and The Book of Questions: Business, Politics, and Ethics. Stock is working on a new book, On the Cusp: The Promise of Nextgen Healthcare, that explores the coming disruptive data-and-technology-driven transformation of healthcare.
Dr. Stock has been profiled in the Wall Street Journal, New York Times, MIT Tech Review and Lancet. He makes regular appearances on television and radio, including CNN, PBS, NPR, Bloomberg, and the BBC, and he has been in dozens of one-on-one debates about healthcare and policy with Francis Fukuyama, Jeremy Rifkin, Leon Kass, Dan Callahan, Ray Kurzweil, and other prominent figures.
Stock serves on the California Advisory Committee on Stem Cells and Reproductive Cloning, and on the Board of Directors of Signum Biosciences, Nutralogix, and Napo Pharmaceuticals. He has a PhD in Biophysics from Johns Hopkins and an MBA from Harvard.
- On the Cusp: The Promise of Nextgen Healthcare (Forthcoming)
- The Book of Questions (2013)
- Redesigning Humans: Our Inevitable Genetic Future (2004)
- Engineering the Human Germline (2000)
- Metaman: The Merging of Humans and Machines into a Global Superorganism (1994)
- Business, Politics and Ethics: The Book of Questions; The Kids’ Book of Questions; Love and Sex: The Book of Questions; The Book of Questions (1990-1992)
- Phi Beta Kappa
- Baker Scholar
- Kistler Award for Best Science Book
- Freund Porter Entrepreneurship Prize
- Jasse Award for Leadership
- Fellow of World Academy of Arts and Science
- Sloan Foundation Presidential Grant
- Wired Magazine Rave Award Nominee
- NY Times Bestseller List (26 Weeks)
“Gregory was excellent, from his performance, content and style. He presented well and responded well to questions.”
Presentation Languages: English